Effect of genetic polymorphisms on therapeutic response and clinical outcomes in pancreatic cancer patients treated with gemcitabine

By Woo Hye In   Kim Ka-Kyung   Choi Hangseok   Kim Seonwoo   Jang Kee-Taek   Yi Jun Ho   Park Young Suk   Park Joon Oh   Lee Soo-Youn  

Pharmacogenomics, Vol. 13, Iss. 9, 2012-07 ,pp. : 1023-1035

Future Medicine

Access to resources Recommend Favorite

Population Pharmacokinetics of Itraconazole and its Active Metabolite Hydroxy-Itraconazole in Paediatric Cystic Fibrosis and Bone Marrow Transplant Patients

By Hennig Stefanie   Wainwright Claire E.   Bell Scott C.   Miller Hugh   Friberg Lena E.   Charles Bruce G.  

Clinical Pharmacokinetics, Vol. 45, Iss. 11, 2006-01 ,pp. : 1099-1114

Adis International

Access to resources Recommend Favorite

Population pharmacokinetic modeling of motesanib and its active metabolite, M4, in cancer patients

By  

Clinical Pharmacology In Drug Development, Vol. 4, Iss. 6, 2015-11 ,pp. : 463-472

John Wiley & Sons Inc

Access to resources Recommend Favorite

Pharmacokinetics of Metrifonate and its Metabolite Dichlorvos in Healthy Volunteers and in Patients with Renal Impairment

By Heinig R.  

Clinical Drug Investigation, Vol. 18, Iss. 1, 1999-07 ,pp. : 35-46

Adis International

Access to resources Recommend Favorite

Population Pharmacokinetics of Haloperidol Using Routine Clinical Pharmacokinetic Data in Japanese Patients

By Yukawa E.  

Clinical Pharmacokinetics, Vol. 41, Iss. 2, 2002-01 ,pp. : 153-159

Adis International

Access to resources Recommend Favorite